New price of dabrafenib released in 2024

Dabrafenib is a targeted therapy drug used to treat certain types of cancer, particularly malignant melanoma (melanoma) and non-small cell lung cancer. It belongs to a class of drugs called BRAF kinase inhibitors, which target tumors with mutations in the BRAF gene.

Dabrafenib is now on the market in China and has been included in medical insurance. Patients can purchase it domestically. However, its price is relatively high, about 10,000 yuan, and you need to consult the local hospital pharmacy for the specific price. In comparison, the price of foreign generic drugs of dabrafenib is more affordable, especially the price of generic drugs in Laos, which is only about two to three thousand yuan, which is far lower than the domestic price. It needs to be emphasized that the pharmaceutical ingredients of these foreign generic drugs are basically the same as those of domestic original drugs. Therefore, patients can flexibly choose a suitable drug source based on their own economic situation and actual needs.

BRAF is a key protein in cell signaling pathways and is involved in regulating cell growth and division. However, when the BRAF gene is mutated, it will lead to abnormal activation of the BRAF protein and promote abnormal proliferation and growth of tumor cells. The mechanism of action of dabrafenib is to inhibit the activity of BRAF protein and block the excessive activation of downstream signaling pathways, thereby inhibiting the proliferation and spread of cancer cells.

In cancers such as malignant melanoma and non-small cell lung cancer, patients may carry specific mutations in the BRAF gene, such as the BRAF V600E or V600K mutation. Dabrafenib targets these mutations and provides an effective treatment option that helps control tumor growth and progression.

Dabrafenib is usually administered as an oral tablet, and dosage and administration are usually based on the patient's specific condition and severity of illness. During use, patients may experience some side effects, such as skin reactions, fever, fatigue, etc. Therefore, before using dabrafenib, patients should receive physician evaluation and guidance, and the response during treatment should be closely monitored to ensure optimal therapeutic effect and safety.